Johns Hopkins scientists zero in on how cancers resist immunotherapy treatment – The Hub at Johns Hopkins
The Hub at Johns Hopkins |
Johns Hopkins scientists zero in on how cancers resist immunotherapy treatment
The Hub at Johns Hopkins Results of an initial study of tumors from patients with certain cancers she light on the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors. The study, conducted by researchers on five patients at the Johns Hopkins … Editorial: Tampa Bay's leadership on immunotherapy | Tampa Bay … Some Cancer Cells Hide Mutations to Impair Immune Recognition, Study Finds Nanoparticles awaken immune cells to fight cancer | Science | AAAS |
